Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Eliopoulos

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
Phase 0 trials: an industry perspectiveHelen Eliopoulos, Vincent Giranda, Robert Carr, et al.
Journal of Neuromuscular Diseases|February 1, 2021
Comparison of Long-term Ambulatory Function in Patients with Duchenne Muscular Dystrophy Treated with Eteplirsen and Matched Natural History ControlsJerry R Mendell, Navid Khan, Nanshi Sha, et al.
Journal of Neuromuscular Diseases|March 12, 2019
Eteplirsen Treatment Attenuates Respiratory Decline in Ambulatory and Non-Ambulatory Patients with Duchenne Muscular DystrophyNavid Khan, Helen Eliopoulos, Lixin Han, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2009
Phase 0 clinical trial of the poly (ADP-ribose) polymerase inhibitor ABT-888 in patients with advanced malignanciesShivaani Kummar, Robert Kinders, Martin E Gutierrez, et al.
Medicine|July 3, 2019
Long-term treatment with eteplirsen in nonambulatory patients with Duchenne muscular dystrophyLindsay N Alfano, Jay S Charleston, Anne M Connolly, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
Phase 0 trials: an industry perspectiveHelen Eliopoulos, Vincent Giranda, Robert Carr, et al.
Journal of Neuromuscular Diseases|February 1, 2021
Comparison of Long-term Ambulatory Function in Patients with Duchenne Muscular Dystrophy Treated with Eteplirsen and Matched Natural History ControlsJerry R Mendell, Navid Khan, Nanshi Sha, et al.
Journal of Neuromuscular Diseases|March 12, 2019
Eteplirsen Treatment Attenuates Respiratory Decline in Ambulatory and Non-Ambulatory Patients with Duchenne Muscular DystrophyNavid Khan, Helen Eliopoulos, Lixin Han, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2009
Phase 0 clinical trial of the poly (ADP-ribose) polymerase inhibitor ABT-888 in patients with advanced malignanciesShivaani Kummar, Robert Kinders, Martin E Gutierrez, et al.
Medicine|July 3, 2019
Long-term treatment with eteplirsen in nonambulatory patients with Duchenne muscular dystrophyLindsay N Alfano, Jay S Charleston, Anne M Connolly, et al.
Pageof 1